Skip to content

Clinical trials

Phase 3 Hypercholesterolemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypercholesterolemia Phase: Phase 3 Clear all

265 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20006
20013
200214
200317
200415
200525
200612
200719
200811
20095
20103
20119
201212
201318
20148
20159
201613
20177
20184
20194
20206
20219
20226
20238
20246
20251
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed222
Terminated22
Recruiting7
Active, not recruiting5
Unknown status3
Not yet recruiting2
Enrolling by invitation2
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Organon and Co56
AstraZeneca24
Amgen22
Sanofi22
Merck Sharp & Dohme LLC15
Takeda12
Novartis Pharmaceuticals10
Kowa Research Europe7
Esperion Therapeutics, Inc.6
LIB Therapeutics LLC6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypercholesterolemia265
Hyperlipidemias47
Dyslipidemias46
Hyperlipoproteinemia Type II24
Atherosclerosis23
Coronary Disease20
Cardiovascular Diseases16
Hypertension16
Diabetes Mellitus10
Homozygous Familial Hypercholesterolemia7

Trials

Showing 76 to 100 of 265. Each trial links to its page on Pharma Observatory.

165 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.